EMA workshop on primary efficacy endpoints for antivirals and monoclonal antibodies intended for the treatment of COVID-19 and influenza held the 5 June 2025: publication of the video recordings of the event
The workshop was organised to bring together academic, regulatory, industry and healthcare professionals. It discussed similarities and major challenges experienced with the clinical study design in antiviral treatment trials for COVID-19 and influenza. It also...





